Guardant Health Inc (GH) - Medical Equipment - Deals and Alliances Profile
November 2018
38
About the Report
About the Report
Summary
Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection used during cancer treatment for residual disease monitoring and recurrence monitoring. Guardant Health also develops a cloud-based information platform for liquid biopsy-based genomic testing in cancer treatments. The company provides somatic alterations across all solid tumor sites. Guardant Health is headquartered in Redwood City, California, the US.
Guardant Health Inc (GH)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Guardant Health Inc , Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises USD 31.5 Million In Series B Venture Financing 18
Guardant Health Raises USD 10 Million In Series A Financing Round 19
Partnerships 20
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Equity Offering 29
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc-Key Competitors 30
Guardant Health Inc-Key Employees 31
Guardant Health Inc-Locations And Subsidiaries 32
Head Office 32
Recent Developments 33
Legal and Regulatory 33
Jul 18, 2018: Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit 33
Product News 34
Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 34
Other Significant Developments 35
Sep 05, 2018: Guardant Health reports cyber attack and information breach 35
Jun 03, 2017: Cure-One Announces Partnership with Guardant Health 36
May 11, 2017: Guardant Health Partners with SoftBank to Accelerate Efforts in Early Cancer Detection 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Figure
List of Figures
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Guardant Health Inc, Medical Equipment, Key Facts, 2017 2
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Guardant Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Guardant Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Guardant Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Guardant Health Inc, Deals By Market, 2012 to YTD 2018 8
Guardant Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Guardant Health Raises USD360 Million in Venture Financing 11
Guardant Health Raises Funds in Series D Financing Round 13
Guardant Health Raises USD83 Million in Venture Financing 15
Guardant Health Raises USD50 Million in Series C Venture Financing 16
Guardant Health Raises USD56 Million in Venture Financing 17
Guardant Health Raises USD 31.5 Million In Series B Venture Financing 18
Guardant Health Raises USD 10 Million In Series A Financing Round 19
Guardant Health Enters into Agreement with Bristol-Myers 20
University of Texas MD Anderson Cancer Center Enters into Agreement with Guardant Health 21
Guardant Health Enters into Agreement with AstraZeneca, Merck and Pfizer 22
Guardant Health Enters into Distribution Agreement with IPS Genomix 23
Oncotest-Teva Enters into Distribution Agreement with Guardant Health 24
Guardant Health, Pangaea Biotech, Dr. Rosell Oncology Institute and Medica Scientia Innovation Research Enter into Agreement 25
Guardant Health Enters into Agreement with Principia Biopharma 26
Guardant Health Enters into Distribution Agreement with Sanomics 27
Guardant Health Enters into Agreement with Mirati Therapeutics 28
Guardant Health Raises USD273.1 Million in IPO 29
Guardant Health Inc, Key Competitors 30
Guardant Health Inc, Key Employees 31
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.